Sandbox 77

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 15: Line 15:
== References ==
== References ==
-
{{cite journal |last=Berumen |first=Laura Cristina |last2=Rodriguez |first2=Angelina |last3=Miledi |first3=Ricardo |last4=Garcia-Alcocer |first4=Guadalupe |date= 2 May 2015 |title= [Serotonin Receptors in Hippocampus.] |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353568 |journal=The Scientific World Journal |publisher=The Scientific World Journal |volume= |issue= |pages= |doi= |access-date=15 November 2015}}
 
-
{{cite journal |last=Goodsell |first=David |date=Aug 2013 |title=”Serotonin Receptor.|url=http://www.rcsb.org/pdb/101/motm.do?momID=164|access-date= 2015}}
+
1. {{journal |last=Berumen |first=Laura Cristina |last2=Rodriguez |first2=Angelina |last3=Miledi |first3=Ricardo |last4=Garcia-Alcocer |first4=Guadalupe |date= 2 May 2015 |title= [''Serotonin Receptors in Hippocampus''.] |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353568 |journal=The Scientific World Journal |publisher=The Scientific World Journal |volume= |issue= |pages= |doi= |access-date=15 November 2015}}
-
{{cite journal |last=Wiebke |first=Janssen |last2=Schymura |first2=Yves |last3=Novoyatleva |first3=Tatyana |last4=Kojonazarov |first4=Baktybek |last5=Boehm |first5=Mario |last6=Wietelmann |first6=Astrid |last7=Luitel |first7=Himal |last8=Murmann |first8=Kristen |last9=Krompiec |first9=Damian Richard |last10=Tretyn |first10=Aleksandra |last11=Pullamsetti |first 11=Soni Savi |last12=Weissmann |first12=Norbert |last13=Seeger |first13=Werner |last14=Ghofrani |first14=Hossein Ardeschir |last15=Schermuly |first15=Ralph Theo |date=1 February 2015 |title=”5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312574 |journal=BioMed Research International |publisher=Hindawi Publishing corporation |access-date=15 November 2015}}
+
2. {{journal |last=Goodsell |first=David |date=Aug 2013 |title=”Serotonin Receptor.” |url=http://www.rcsb.org/pdb/101/motm.do?momID=164|access-date= 2015}}
-
{{cite web |last=Nebigil |last2=Etienne |last3=Schaerlinger |last4=Hickel |last5=Launay |last6=Maroteaux |date=22 May 2001 |title=Developmentally Regulated Serotonin 5-HT2B Receptors.” |url=http://www.sciencedirect.com/science/article/pii/S0736574801000223 publisher=Sciencedirect |access-date=15 November 2015}}
+
3. {{journal |last=Wiebke |first=Janssen |last2=Schymura |first2=Yves |last3=Novoyatleva |first3=Tatyana |last4=Kojonazarov |first4=Baktybek |last5=Boehm |first5=Mario |last6=Wietelmann |first6=Astrid |last7=Luitel |first7=Himal |last8=Murmann |first8=Kristen |last9=Krompiec |first9=Damian Richard |last10=Tretyn |first10=Aleksandra |last11=Pullamsetti |first 11=Soni Savi |last12=Weissmann |first12=Norbert |last13=Seeger |first13=Werner |last14=Ghofrani |first14=Hossein Ardeschir |last15=Schermuly |first15=Ralph Theo |date=1 February 2015 |title=”5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312574 |journal=BioMed Research International |publisher=Hindawi Publishing corporation |access-date=15 November 2015}}
-
{{cite web |last=Thompson |first=A. J. |last2=Lummis |first2=S. C. R. |date=2 April 2009 |title=”%-HT3 Receptors.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664614/ |journal=Current Pharmaceutical Design |publisher=U.S. National Library of Medicine |access-date=15 November 2015}}
+
4. {{journal |last=Nebigil |last2=Etienne |last3=Schaerlinger |last4=Hickel |last5=Launay |last6=Maroteaux |date=22 May 2001 |title=Developmentally Regulated Serotonin 5-HT2B Receptors.” |url=http://www.sciencedirect.com/science/article/pii/S0736574801000223 publisher=Sciencedirect |access-date=15 November 2015}}
-
{{cite journal |last=Wang |last2=Chong |last3=Jiang |first3=Yi |last4= Ma |first4=Jinming |last5=Wu |first5=Huixian |last6=Wacker |first6=Daniel |last7=Katritch |first7=Vsevolod |last8=Han |first8=Gye Won |last9=Liu |first9=Wei |last10=Huang |first10Xi-Ping |last11=Vardy |first11=Eval |last12=McCorvy |first12=John D. |last13=Gao |first13=Xiang |last14=Zhou |first14=Edward X. Zhou |last15=Melcher |first15=Karsten |last16=Zhang |first16=Chenghai |last17=Bai |first17=Fang |last18=Yang |first18=Huaiyu |last19=Yang |first19=Linlin |last20=Jiang |first20=Hualiang |last21=Roth |first21=Bryan L. |last22=Cherezov |first22=Vadim |last23=Stevens |first23=Raymond C. |last24=Xu |first24=H. Eric |date=21 March 2013 |title=”Structural Basis for Molecular Recognition at Serotonin Receptors.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644373/ |journal=Science |publisher=U.S. National Library of Medicine |access-date=15 November 2015}}
+
5. {{journal |last=Thompson |first=A. J. |last2=Lummis |first2=S. C. R. |date=2 April 2009 |title=”%-HT3 Receptors.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664614/ |journal=Current Pharmaceutical Design |publisher=U.S. National Library of Medicine |access-date=15 November 2015}}
 +
 
 +
6. {{journal |last=Wang |last2=Chong |last3=Jiang |first3=Yi |last4= Ma |first4=Jinming |last5=Wu |first5=Huixian |last6=Wacker |first6=Daniel |last7=Katritch |first7=Vsevolod |last8=Han |first8=Gye Won |last9=Liu |first9=Wei |last10=Huang |first10Xi-Ping |last11=Vardy |first11=Eval |last12=McCorvy |first12=John D. |last13=Gao |first13=Xiang |last14=Zhou |first14=Edward X. Zhou |last15=Melcher |first15=Karsten |last16=Zhang |first16=Chenghai |last17=Bai |first17=Fang |last18=Yang |first18=Huaiyu |last19=Yang |first19=Linlin |last20=Jiang |first20=Hualiang |last21=Roth |first21=Bryan L. |last22=Cherezov |first22=Vadim |last23=Stevens |first23=Raymond C. |last24=Xu |first24=H. Eric |date=21 March 2013 |title=”Structural Basis for Molecular Recognition at Serotonin Receptors.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644373/ |journal=Science |publisher=U.S. National Library of Medicine |access-date=15 November 2015}}

Revision as of 22:08, 4 December 2015

Contents

General Function

5-HT3 Receptor

Drag the structure with the mouse to rotate

5-HT, Serotonin, receptors are found on the membrane of neurons in the central nervous system and peripheral nervous system. These receptors allow for the body to respond to serotonin and regulate many biological pathways. Serotonin, also known as 5 hydroxytryptamine, is an endogenous neurotransmitter made from tryptophan and is largely found in the gastrointestinal tract. 5-HT receptors are classified into 7 different subfamilies (5-HT1, 5-HT2, 5-HT3, etc.) by signaling mechanisms and homology of structure. All 5-HT receptors are known to have G-protein linked pathways except for the 5-HT3 receptor which acts as an ion channel. (Wang, et al. 2013).

Structural highlights/Specific Function of 5-HT1B

The 5-HT1B receptor couples to G-protein alpha subunits Gi and Go. In the central nervous system, this receptor is an inhibitory presynaptic receptor that can alter the release of serotonin, as well as other neurotransmitters, from the presynaptic neuron. The structure of this receptor includes 7 transmembrane alpha-helices in its center. The N-terminal tail of 5-HT1B is close to the ligand binding pocket suggesting some interaction with its ligand. The orthosteric, unmodulated, binding pocket is characterized as a cavity formed from residues of the 3rd, 5th, 6th, and 7th alpha helices and the 2nd extracellular loop. (Wang, et al. 2013)

Structural highlights/Specific Function of 5-HT2B

The 5-HT2B receptor is important in utilizing serotonin signals to encourage proper development and continuing function of the cardiovascular system. Overexpression of 5-HT2B has been linked to congestive heart failure. (Janssen, et al. 2015) 5-HT2B utilizes the alpha Gq protein pathway which triggers intracellular cGMP production through activation of nictric-oxidase synthase (NOS). (Nebigil, et al. 2001) This receptor is also known for being the target of the drug LSD, which has similar structure to serotonin. (Berumen, et al. 2012) The structure of this receptor is much like that of 5-HT1B. It has the characteristic 7 alpha helices and the N-terminus sticks out into extracellular space. (Wang, et al. 2013)

Structural highlights/Specific Function of 5-HT3

The 5-HT3 receptor is a pentameric cation-selective ion channel and plays a role in neuronal excitation to release neurotransmitters from the postsynaptic neuron. 5-HT3 is usually comprised of subunits A or A and B which can result in a homopentameric receptor or a heteropentameric receptor respectively. 5-HT3 is a transmembrane channel that is stimulated to open state by the interaction of the receptor with serotonin in the extracellular space. The binding site is comprised of six loops from two adjacent subunits.The transmembrane region is comprised of multiple alpha helical structures and mediates ion flow and ion specificity. Sodium and Potassium ions are allowed to pass through the 5-HT3 receptor pore. This receptor is involved in the transfer of information to the gastrointestinal tract which makes it a target of drugs which repress vomiting and irritable bowel syndrome.


References

1. Pancholi, V. "Multifunctional a-Enolase: Its Role in Diseases." CMLS, Cellular and Molecular Life Sciences 58 (2001): 902-20.

2. Pancholi, V. "Multifunctional a-Enolase: Its Role in Diseases." CMLS, Cellular and Molecular Life Sciences 58 (2001): 902-20.

3. Pancholi, V. "Multifunctional a-Enolase: Its Role in Diseases." CMLS, Cellular and Molecular Life Sciences 58 (2001): 902-20.

4. Pancholi, V. "Multifunctional a-Enolase: Its Role in Diseases." CMLS, Cellular and Molecular Life Sciences 58 (2001): 902-20.

5. Pancholi, V. "Multifunctional a-Enolase: Its Role in Diseases." CMLS, Cellular and Molecular Life Sciences 58 (2001): 902-20.

6. Pancholi, V. "Multifunctional a-Enolase: Its Role in Diseases." CMLS, Cellular and Molecular Life Sciences 58 (2001): 902-20.

Personal tools